Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21FN2O2 |
InChIKeyHBJAOVQVJNRNPY-UHFFFAOYSA-N |
CAS Registry866843-00-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Feb 2019 |